Showing 5061-5070 of 5693 results for "".
- Topcon Announces Customer Initiatives to Combat Global COVID-19 Crisishttps://modernod.com/news/topcon-announces-customer-initiatives-to-combat-global-covid-19-crisis/2477421/As the COVID-19 pandemic continues to escalate across the globe, Topcon Healthcare has announced a series of initiatives and programs designed to support its customers during this time of unprecedented challenges. As healthcare providers, eye doctors are required to be in close contact wit
- Trump Touts Drug That FDA Says Isn’t Yet Approved for Virushttps://modernod.com/news/trump-touts-drug-that-fda-says-isnt-yet-approved-for-virus/2477422/The Food and Drug Administration has been told by President Donald Trump to see if it can expand the use of a decades-old malaria drug as an experimental treatment for coronavirus patients, as
- Retina Specialists Share How They Are Adjusting to COVID-19https://modernod.com/news/retina-specialists-share-how-they-are-adjusting-to-covid-19/2477416/As the novel coronavirus outbreak continues to spread in the United States, retina clinics—who often see older patients who are more at risk of virus complications—are making a number of adjustments. Rishi P. Singh, MD, staff physician at the Cole Eye Institute at the Cleveland Clinic, whe
- Roche Initiates Phase 3 Trial of Actemra/RoActemra in Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/roche-initiates-phase-3-trial-of-actemra-roactemra-in-patients-with-severe-covid-19-pneumonia/2477410/Roche announced it is working with the FDA to initiate a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of th
- Chinese Official Claims Fujifilm’s Avigan “Clearly Effective” in Treating COVID-19https://modernod.com/news/chinese-official-claims-fujifilms-avigan-clearly-effective-in-treating-covid-19/2477411/Results of clinical studies conducted in China suggest that Fujifilm’s Avigan (favipiravir) may be effective at treating patients with COVID-19. Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, remarked “it
- Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assayhttps://modernod.com/news/quidel-receives-emergency-use-authorization-for-molecular-covid-19-diagnostic-assay/2477407/Quidel, a provider of rapid diagnostic testing solutions, announced that the company has received Emergency Use Authorization (EUA) from the FDA to market its Lyra SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or
- Sight Sciences Announces $30 Million Financinghttps://modernod.com/news/sight-sciences-announces-30-million-financing/2477405/Sight Sciences announced the closing of an over $30 million Series E Preferred Stock financing round led by D1 Capital Partners. Proceeds will be used for continued clinical and operational development and to support commercial expansion for Sight Sciences’ OMN
- Ribomic Enters License Agreement with AJU Pharma for RBM-007 in AMDhttps://modernod.com/news/ribomic-enters-license-agreement-with-aju-pharma-for-rbm-007-in-amd/2477400/Ribomic announced that it has signed a license agreement with Korean pharmaceutical company AJU Pharm Co. for RBM-007 for the indication of the exudative age-related macular degeneration (AMD) in the territory of Korea and Southeast Asia (Singapore, Philippines, Thailand, Vietnam, Indonesia, Mala
- AAO Provides Updated COVID-19 Guidance for Outpatient Clinics and Elective Surgeryhttps://modernod.com/news/aao-provides-updated-guidance-for-outpatient-clinics-and-elective-surgery/2477395/In response to the state of national emergency declared at the federal level, particularly as COVID-19 progresses in a given community, ophthalmologists should seriously consider both the intensity of clinic scheduling and the issue of elective surgeries, particularly in elderly patients and thos
- The Outpatient Ophthalmic Surgery Society (OOSS) Releases Statement Regarding COVID-19 Outbreakhttps://modernod.com/news/ooss-releases-statement-regarding-covid-19-outbreak/2477392/The Outpatient Ophthalmic Surgery Society (OOSS) has released a statement to its membership providing information and resources on how to establish ASC procedures if your community is directly affected by the COVID-19 outbreak. The statement reads: Dear Colleagues, In the cu